The United States Congress is currently refining the details of a Nanotechnology Research and Development Act. In contrast to the earlier investments, this new Act specifically calls for a focus on the societal and ethical implications of nanotechnology (SEIN). The Advocates of SEIN studies point to the difficult reception for genetically-modified organisms (GMOs), a technology that promised a new green revolution but encountered resistance in Europe, Canada, and other parts of the world.
No takes yet. Share an insight, caveat, or question.
Gorman et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: